Cannabis for Anxious, Autistic Kids: Pioneering Pediatric Trials
A group of Australian researchers are studying the benefits children could receive if treated with medicinal cannabis for issues with their developing brains.
Medigrowth has partnered with several universities, one of them being the Deakin University, to perform trials utilizing low-potency cannabis. Trials, conducted among children five to twelve, are ongoing.
Cannabis relieves symptoms of ADHD, anxiety, and autism. In one trial, the team monitored changes in behaviour alongside anxiety, treating 29 patients.
Parents say subtle benefits allow children to cope better in school and at home.
Medicos administer the children’s medicine, repeatedly checking them through tests and clear protocols.
Medigrowth chief executive Adam Guskich says clear studies provide people trust in medicines containing cannabis. Measurable doses of cannabis can help children to cope with symptoms if other medicines are not working.
It offers hope to those who have few other options.
The team gathered data through tests, questionnaires, and clinical assessments.
Source: Herald Sun
Green Retail, Safer Streets: How Cannabis Dispensaries Cut Opioid Deaths
States with concentrated areas of cannabis shops have reduced numbers of opium mortality, observed car accidents spike, nor observed spike in suicides, reports a study by the American Journal of Drug and Alcohol Abuse.
A research study by the Public Health Institute out of California looked at the relationship between the density of areas containing cannabis shops and mortality by car accidents, opium poisoning, homicides, poisoning by accident, and suicide across the state of Washington.
They found a greater concentration of recreational cannabis shops significantly correlating with a reduction in numbers of both opium as well as accidental poisoning mortalities.
It appears, according to a research study, that these reductions may result from people substituting opium, alcohol, or other substances with cannabis.
Source: Norml
CBN for Better Sleep: The New Sleep Aid on the Block
Scientists study cannabinol (CBN) as an over-the-counter sleep aid. CBN forms when THC degrades over time. Scientists explain CBN relaxes the body but does not get you high.
An experiment gave individuals a 20-mg CBN dosage. Patients experienced less waking during the night, and their sleep quality improved.
An experiment tested CBN against a placebo. Numbers show CBN keeps individuals asleep.
Research attributes CBN’s effect to its operation on the endocannabinoid system, which governs sleep, mood, and stress.
Dispensaries sell CBN products like drops, honey sticks, and gummies. Many users say CBN makes them fall asleep, remain asleep, and wake again without any groggy feeling.
Specialists are calling for studies to determine the best dosage and longer-term benefits.
Early findings show CBN alone may be more effective if other cannabinoids compounds are not used alongside it.
Source: Nymag
Spain’s New Medical Cannabis Decree: Bridging Human and Veterinary Health
Spain’s Ministry of Health issued a draft decree governing the use of medical cannabis.
Treatment of diseases such as endometriosis and multiple sclerosis, as well as treatment-resistant epilepsy, are treated by the decree.
New formulations containing cannabis reduce pain, says Dr. Javier Calaveras. He cites medicines such as Nabilona, as well as Epidiolex that have reduced symptoms by chronic sufferers.
Vets also use products containing cannabis.
CBD products, says Marian Belloso, relieve pets from suffering and give them mobility.Arthritic pets, both canine and feline, can enjoy these products.
Research work by humans and animals, health receives support from the decree and opens it up to people.
Health officers invite medical, patient, and veterinary consultations.
Source: Cadenaser
Cannabis Eases Arthritis Pain: New Study Shows Relief
A clinical trial conducted in the United States tests cannabis-based therapy for arthritis pain. The researchers sign up patients suffering from chronic joint pain.
They administer a standardized treatment based on cannabis over several months. The study takes measurements of joint functioning and pain levels before and after treatment.
Patients achieve decreased pain scores, as well as increased joint mobility. Physicians measured changes through tests and questionnaires. Most patients decreased their over-the-counter painkiller use.
The study reveals that cannabis-based therapy has an anti-inflammatory effect, as well as an analgesic effect, reducing arthritis patients’ suffering.
The researchers compared the treatment to usual pain relief drugs. The data reveals that the patients have less occurrences of undesirable side effects, when compared to when they are treated by the usual pharmaceutical drugs.
Most patients do not experience severe drowsiness or any gastrointestinal issues. The study employs objective criteria to assess quality of life.
They add that many arthritis sufferers find it problematic to cope with pharmaceutical drugs because of their undesirable side effects.
Cannabis-based therapies are a good option with an excellent safety profile.
The study team urges further studies aimed at confirming these findings.
Source: Yale
